Israel: Most medical marijuana users benefit from treatment, finds first-of-its-kind study
The first study on the characteristics of patients with Health Ministry permission for treatment with medical marijuana – until now an unknown field – was revealed on Wednesday at the Sixth International Jerusalem Conference on Health Policy.
The conference was organized by the Israel National Institute for Health Policy Research.
The study was led by Prof. Pesach Shvartzman of Ben-Gurion University of the Negev’s Health Sciences Faculty, who said even though medical cannabis has been legal for a decade and is licensed to more than 20,000 patients for relieving pain and other symptoms, “there has been no information about the users themselves.”
Shvartzman concluded that most users enjoy significant improvement in pain and function, but that the cannabis also caused side effects.
The study, carried out to observe new patients using the drug for two years, looked at their socioeconomic characteristics, disease profiles, the medical indication for use, dosages, treatment...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin